• Perrigo Co., of Allegan, Mich., completed the acquisition of Rosemont Pharmaceuticals Ltd., of Leeds, UK, for approximately £180 million ($283 million) in cash. Rosemont, a specialty and generic prescription pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations, had 2012 net sales of approximately £40 million.